Abstract
Bridging for antiplatelet therapy remains a subject of debate with data favoring GP blockers but at a risk of bleeding. This Conversation in Cardiology addresses a key and often asked question about use of alternatives to P2Y12 agents in patients requiring surgery within 6 months after drug eluting stent implantation.
Keywords:
antiplatelet therapy; stent thrombosis.
Copyright © 2013 Wiley Periodicals, Inc.
MeSH terms
-
Coronary Thrombosis / economics
-
Coronary Thrombosis / etiology
-
Coronary Thrombosis / prevention & control*
-
Cost-Benefit Analysis
-
Drug Administration Schedule
-
Drug Costs
-
Hemorrhage / chemically induced
-
Humans
-
Percutaneous Coronary Intervention* / adverse effects
-
Perioperative Care
-
Platelet Aggregation Inhibitors / administration & dosage*
-
Platelet Aggregation Inhibitors / adverse effects
-
Platelet Aggregation Inhibitors / economics
-
Purinergic P2Y Receptor Antagonists / administration & dosage*
-
Purinergic P2Y Receptor Antagonists / adverse effects
-
Purinergic P2Y Receptor Antagonists / economics
-
Surgical Procedures, Operative* / economics
-
Time Factors
-
Treatment Outcome
Substances
-
Platelet Aggregation Inhibitors
-
Purinergic P2Y Receptor Antagonists